Supplements and Featured Publications

Medication-Assisted Treatment: New Innovations and Opportunities for Opioid and Alcohol Use Disorders

Medication-Assisted Treatment: New Innovations and Opportunities for Opioid and Alcohol Use Disorders

Translating Clinical Evidence Into Value-Based Payment Models: Pooled Analyses of Innovative Real-World Outcomes Agreements for Ticagrelor in the United States

Translating Clinical Evidence Into Value-Based Payment Models: Pooled Analyses of Innovative Real-World Outcomes Agreements for Ticagrelor in the United States

Volume: 26
Issue: 13
Examining the Clinical and Economic Burden of OFF Periods in Parkinson Disease

Examining the Clinical and Economic Burden of OFF Periods in Parkinson Disease

Volume: 26
Issue: 12
Managed Care Considerations for Chronic Cough

Managed Care Considerations for Chronic Cough

Volume: 26
Issue: 11
Hepatocellular Carcinoma: Examining the Latest Evidence for Managed Care

Hepatocellular Carcinoma: Examining the Latest Evidence for Managed Care

Volume: 26
Issue: 10
Lowering Out-of-Pocket Costs for Older Adults: A Guide

Lowering Out-of-Pocket Costs for Older Adults: A Guide

Worsening Heart Failure: Clinical and Managed Care Considerations

Worsening Heart Failure: Clinical and Managed Care Considerations

Efficacy and Safety of Mavacamten in Adults With Symptomatic Obstructive Hypertrophic Cardiomyopathy: Results of the EXPLORER-HCM Study

Efficacy and Safety of Mavacamten in Adults With Symptomatic Obstructive Hypertrophic Cardiomyopathy: Results of the EXPLORER-HCM Study

The Role of SGLT-2 Inhibitors in Heart Failure: A Roundtable Discussion

The Role of SGLT-2 Inhibitors in Heart Failure: A Roundtable Discussion

Multiple Sclerosis Compendium Newsletter

Multiple Sclerosis Compendium Newsletter

Type 2 Diabetes: Current Data and Innovative Practices

Type 2 Diabetes: Current Data and Innovative Practices

Understanding the Mechanisms of Multiple Sclerosis Treatments

Understanding the Mechanisms of Multiple Sclerosis Treatments

Slowing Disease Progression in Amyotrophic Lateral Sclerosis: A Review of Guidelines and Current and Emerging Therapies

Slowing Disease Progression in Amyotrophic Lateral Sclerosis: A Review of Guidelines and Current and Emerging Therapies

Volume: 26
Issue: 9
Addressing Unmet Needs in Alzheimer Disease: Implications of Delayed Diagnosis and Examining New and Emerging Therapies

Addressing Unmet Needs in Alzheimer Disease: Implications of Delayed Diagnosis and Examining New and Emerging Therapies

Volume: 26
Issue: 8
The Challenges in Long-Chain Fatty Acid Oxidation Disorders: Unmet Needs of Treatment and Management

The Challenges in Long-Chain Fatty Acid Oxidation Disorders: Unmet Needs of Treatment and Management

Volume: 26
Issue: 7
Optimizing the Use of Molecular Testing in Lung Cancer: An AJMC Stakeholder Interchange Report

Optimizing the Use of Molecular Testing in Lung Cancer: An AJMC Stakeholder Interchange Report

Comparing Factor Use and Bleed Rates in US Hemophilia A Patients Receiving Prophylaxis With 3 Different Long-Acting Recombinant Factor VIII Products

Comparing Factor Use and Bleed Rates in US Hemophilia A Patients Receiving Prophylaxis With 3 Different Long-Acting Recombinant Factor VIII Products

A Path to Improve Colorectal Cancer Screening Outcomes: Faculty Roundtable Evaluation of Cost-Effectiveness and Utility

A Path to Improve Colorectal Cancer Screening Outcomes: Faculty Roundtable Evaluation of Cost-Effectiveness and Utility

Volume: 26
Issue: 6
Immunoglobulin Potency and Purity Considerations for Patients With Primary Immunodeficiency

Immunoglobulin Potency and Purity Considerations for Patients With Primary Immunodeficiency

Volume: 1
Issue: 1
Addressing an Unmet Need for Acute Treatment of Migraine

Addressing an Unmet Need for Acute Treatment of Migraine

Perspectives on the Value of Icosapent Ethyl

Perspectives on the Value of Icosapent Ethyl

Improving Treatment Strategies for Wet Age-Related Macular Degeneration

Improving Treatment Strategies for Wet Age-Related Macular Degeneration

Volume: 26
Issue: 5
A Managed Care Review on Insomnia: Treatment Guidelines, Emerging Therapies, and the Need for Safe, Effective Options

A Managed Care Review on Insomnia: Treatment Guidelines, Emerging Therapies, and the Need for Safe, Effective Options

Volume: 26
Issue: 4
A Managed Care Review of Schizophrenia: Evaluating Unmet Medical Needs, New Treatments, and Health Economics

A Managed Care Review of Schizophrenia: Evaluating Unmet Medical Needs, New Treatments, and Health Economics

Volume: 26
Issue: 3
Managed Care Considerations for Navigating Biosimilar and HER2-Directed Therapies for the Treatment of HER2-Positive Breast Cancer

Managed Care Considerations for Navigating Biosimilar and HER2-Directed Therapies for the Treatment of HER2-Positive Breast Cancer

Volume: 26
Issue: 2
Evidence-Based Recommendations, Real-World Utilization, and Considerations in the Total Cost of Care in COPD Treatment Strategies

Evidence-Based Recommendations, Real-World Utilization, and Considerations in the Total Cost of Care in COPD Treatment Strategies

Rare Disease: Access, Reimbursement, and Disease Management A Stakeholder Interchange Report

Rare Disease: Access, Reimbursement, and Disease Management A Stakeholder Interchange Report

The Role of Non-Invasive Vagus Nerve Stimulation in the Migraine Treatment Spectrum

The Role of Non-Invasive Vagus Nerve Stimulation in the Migraine Treatment Spectrum

Volume: 26
Issue: 1
Novel Advances in Hereditary Amyloid Transthyretin Amyloidosis: A Stakeholder Interchange Report

Novel Advances in Hereditary Amyloid Transthyretin Amyloidosis: A Stakeholder Interchange Report

Examining the Economic Impact and Implications of Epilepsy

Examining the Economic Impact and Implications of Epilepsy

Brand Logo

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences®

All rights reserved.

Secondary Brand Logo